DOTS in HIV positive patients.
Bedi
Rajinder Singh
RS
D000739:Anecdotes as Topic; D000995:Antitubercular Agents / Q000627:therapeutic use; D002985:Clinical Protocols; D003226:Congresses as Topic; D023801:Directly Observed Therapy; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007194:India; D017211:Treatment Failure; D014388:Tuberculosis, Lymph Node / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology
D000995:Antitubercular Agents